Journal of Contemporary Brachytherapy

Full text

3/2026 vol. 18
Original paper

Early optical coherence tomography biomarkers of radiation maculopathy following ruthenium-106 brachytherapy for uveal melanoma in long-term follow-up

Weronika Mularska 1
,
Maciej Rybak 1
,
Łukasz Tomczyk 2
,
Iwona  Rospond-Kubiak 1

  1. Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland

  2. Department of Food Safety and Quality Management, Poznan University of Life Sciences, Poznan, Poland

J Contemp Brachytherapy 2026; 18, 3: 255–260

DOI: https://doi.org/10.5114/jcb.2026.164752
Data publikacji online: 2026/09/30
Article file
Early optical coherence.pdf
  1. Zemba M, Dumitrescu OM, Gheorghe AG et al. Ocular complications of radiotherapy in uveal melanoma. Cancers (Basel) 2023; 15: 333.
  2. Powell BE, Chin KJ, Finger PT. Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned. Eye 2023; 37: 866-874.
  3. Platt S, Salomao DR, Pulido J. Histologic findings of choroidal vasculopathy in eyes enucleated following radiation therapy for uveal melanoma: radiation choroidopathy. Klin Monbl Augenheilkd 2021; 238: 584-590.
  4. Frizziero L, Midena G, Danieli L et al. Hyperreflective retinal foci (HRF):definition and role of an invaluable OCT sign. J Clin Med 2025; 14: 3021.
  5. Parrozzani R, Midena G, Frizziero L et al. Radiation maculopathy is anticipated by OCT hyperreflective retinal foci: A large, prospective, confirmation study. Retina 2022; 42: 752-759.
  6. Lim LAS, Camp DA, Ancona-Lezama D et al. Wide-field (15 × 9 mm) swept-source optical coherence tomography angiography following plaque radiotherapy of choroidal melanoma: an analysis of 105 eyes. Asia Pac J Ophthalmol 2020; 9: 326-334.
  7. Say EAT, Samara WA, Khoo CTL et al. Parafoveal capillary density after plaque radiotherapy for choroidal melanoma: Analysis of eyes without radiation maculopathy. Retina 2016; 36: 1670-1678.
  8. Shields CL, Say EAT, Samara WA et al. Optical coherence tomography angiography of the macula after plaque radiotherapy of choroidal melanoma: Comparison of irradiated versus nonirradiated eyes in 65 patients. Retina 2016; 36: 1493-1505.
  9. Gündüz K, Shields CL, Shields JA et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999; 117: 609-614.
  10. Lalos F, Flühs D, Guberina M et al. Treatment-related complications and functional results after ruthenium-106 brachytherapy in small to medium size uveal melanomas (Part 2). Klin Monbl Augenheilkd 2025; 242: 116-126.
  11. Bianciotto C, Shields CL, Pirondini C et al. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 2010; 117: 1005-1012.
  12. Miguel D, Frutos-Baraja JMD, Lopez-Lara Martín F et al. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis of single-institution: part II. J Contemp Brachytherapy 2018; 10: 347-359.
  13. Pagliara MM, Tagliaferri L, Azario L et al. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications. Brachytherapy 2018; 17: 432-438.
  14. Peters V, Gurayah A, Jin W et al. Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 eye plaque brachytherapy for uveal melanomas. Brachytherapy 2022; 21: 896-903.
  15. Kumar B, Palimar P. Accelerated radiation retinopathy in diabetes and pregnancy. Eye 2000; 14: 107-108.
  16. Brown GC, Shields JA, Sanborn G et al. Radiation retinopathy. Ophthalmology 1982; 89: 1494-1501.
  17. Horgan N, Shields CL, Mashayekhi A et al. Early macular morphological changes following plaque radiotherapy for uveal melanoma. Retina 2008; 28: 263-273.
  18. Veverka KK, Abou Chehade JE, Iezzi R Jr et al. Nonin-invasive grading of radiation retinopathy: The use of optical coherence tomography angiography. Retina 2015; 35: 2400-2410.
  19. Parrozzani R, Midena E, Trainiti S et al. Identification and classification of macular morphologic biomarkers related to visual acuity in radiation maculopathy. Retina 2020; 40: 1419-1428.
  20. Corona ST, Ali OI, Yu HJ et al. RRR Study Group. Morphological biomarkers related to visual acuity in patients with radiation retinopathy treated with intravitreal ranibizumab. Ophthalmic Surg Lasers Imaging Retina 2024; 55: 255-262.
  21. Turgut B, Yildirim H. The causes of hyperreflective dots in optical coherence tomography excluding diabetic macular edema and retinal venous occlusion§. Open Ophthalmol J 2015; 9: 36-40.
  22. Zhu R, Xiao S, Zhang W et al. Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study. BMC Ophthalmol 2022; 22: 352.
  23. Fragiotta S, Abdolrahimzadeh S, Dolz-Marco R et al. Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J Ophthalmol 2021; 2021: 6096017.
  24. Mashayekhi A, Schönbach E, Shields CL et al. Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema. Ophthalmology 2015; 122: 1023-1029.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications